Policy Notices

• Further Continuation of Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic
  (NOT-OD-22-062)
  Office of the Director, NIH
  

General Notices

• FDA Notice of Special Interest (NOSI) to add COVID-19 Capacity Building Grants to PAR-18-604 Vet-LIRN Network Capacity-Building Projects (Vet-LIRN)
  (NOT-FD-22-006)
  Food and Drug Administration
  

• NIGMS Limitations on Clinical Trial Applications Submitted to the NIH Research Project Grant (Parent R01 Clinical Trial Required)
  (NOT-GM-22-027)
  National Institute of General Medical Sciences
  

• Notice of Technical Assistance Webinar for RFA-MH-22-110 and RFA-MH-22-111
  (NOT-MH-22-155)
  National Institute of Mental Health
  

• Request for Information (RFI): Inviting Comments and Suggestions to Advance Research and Vaccine Development for Coccidioidomycosis (Valley Fever)
  (NOT-AI-22-026)
  National Institute of Allergy and Infectious Diseases
  

• Request for Information (RFI): Input on Ocular Imaging Standards
  (NOT-EY-22-008)
  National Eye Institute
  

• Request for Information (RFI): Inviting Comments and Suggestions on a Framework for the NIH-Wide Strategic Plan for Diversity, Equity, Inclusion, and Accessibility
  (NOT-OD-22-061)
  National Institutes of Health
  

Notice of Changes to Funding Opportunities

• Notice of NIAAA's Participation in PAR-21-358, Risk and Protective Factors of Family Health and Family Level Interventions (R01 - Clinical Trial Optional)
  (NOT-AA-22-010)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Change to Eligibility Information in RFA-AI-21-079, Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
  (NOT-AI-22-031)
  National Institute of Allergy and Infectious Diseases
  

• Notice of NIAMS' Participation in NOT-MD-22-006, "Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities"
  (NOT-AR-22-017)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of NCI Participation in PAR-22-064, "Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional)"
  (NOT-CA-22-048)
  National Cancer Institute
  

• Notice of Correction for PAR-22-091, "Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)"
  (NOT-CA-22-049)
  National Cancer Institute
  

• Notice of Change to RFA-CA-22-001, "Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)"
  (NOT-CA-22-050)
  National Cancer Institute
  

• Notice of Change to RFA-CA-22-003, "Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)"
  (NOT-CA-22-051)
  National Cancer Institute
  

• Notice of Change in Interest Areas Relevant to the NIDDK for PA-20-142 Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
  (NOT-DK-22-012)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Clarification of Eligibility Regarding Foreign Components for PAR-20-084, "NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)"
  (NOT-EB-22-004)
  National Institute of Biomedical Imaging and Bioengineering
  

• NEI Notice of Participation in PAR-22-064, "Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional)"
  (NOT-EY-22-009)
  National Eye Institute
  

• Notice of Correction to Eligibility Information in RFA-HL-23-006, "Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)"
  (NOT-HL-22-008)
  National Heart, Lung, and Blood Institute
  

• Notice of Correction to Specific Areas of Research Interest of Participating Institutes and Centers In RFA-HL-23-006, "Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)"
  (NOT-HL-22-009)
  National Heart, Lung, and Blood Institute
  

• Notice of NINDS Participation in RFA-MD-22-004 "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)".
  (NOT-NS-22-067)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Correction for PAR-22-081 Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)
  (NOT-OD-22-070)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

• Notice of Extension of the Response Date for NOT-OD-22-041 "Request for Information (RFI): Research Challenges and Needs in the Biobehavioral Mechanisms of Aggression
  (NOT-OD-22-071)
  Office of Behavioral and Social Sciences Research
  

• Notice of Correction for PAR-22-088 Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
  (NOT-OD-22-072)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)
  (NOT-CA-22-031)
  National Cancer Institute
  Office of Research on Women's Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
  (NOT-CA-22-044)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Learning Disabilities Research Centers (P50 Clinical Trial Optional)
  (NOT-HD-22-001)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

Requests for Proposal

• NIA Caenorhabditis Intervention Testing Program (CITP) Announces A Call for Compounds to Test for Anti-Aging Activity in Caenorhabditis
  (NOT-AG-22-009)
  National Institute on Aging
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Addressing Cancer-Related Financial Hardship to Improve Patient Outcomes
  (NOT-CA-22-045)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Competitive Revisions to Develop a National Data Driven Action Plan to Advance Diversity and Inclusion in the Dental, Oral, and Craniofacial Research Workforce (R25, T32, T90, and UE5)
  (NOT-DE-21-018)
  National Institute of Dental and Craniofacial Research
  

• Notice of Special Interest (NOSI): Addressing Accessibility Inequities with COVID Home-Based Testing for Individuals with Visual Impairment
  (NOT-EY-22-010)
  National Eye Institute
  

• Notice of Special Interest (NOSI): Inclusion of Economic Factors and Outcomes in Infectious Disease Modeling Studies
  (NOT-GM-22-021)
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Research on barriers to care and risk of HIV-associated comorbidities among vulnerable population groups
  (NOT-HL-22-010)
  National Heart, Lung, and Blood Institute
  

• Notice of Special Interest: Neuro-Glia Mechanisms Governing Complex Behaviors (R01 Clinical Trial Optional)
  (NOT-MH-22-090)
  National Institute of Mental Health
  

• Notice of Special Interest: NIMH Priorities on Research on Aggression and Violence Against Others
  (NOT-MH-22-095)
  National Institute of Mental Health
  

• Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship
  (NOT-OD-22-057)
  Office of the Director, NIH
  John E. Fogarty International Center
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  National Library of Medicine
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Administrative Supplements for Advancing the Ethical Development and Use of AI/ML in Biomedical and Behavioral Sciences
  (NOT-OD-22-065)
  Office of the Director, NIH
  John E. Fogarty International Center
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  

• Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations to Improve the AI/ML-Readiness of NIH-Supported Data
  (NOT-OD-22-067)
  Office of the Director, NIH
  John E. Fogarty International Center
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  

Funding Opportunities

• Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)
  (PAR-22-082)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• NHGRI Short Courses for Genomics-Related Research Education (R25 Clinical Trial Not Allowed)
  (PAR-22-095)
  National Human Genome Research Institute
  Application Receipt Date(s): January 25, 2025
  
  

• Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
  (PAR-22-100)
  National Center for Advancing Translational Sciences
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
  (PAR-22-101)
  National Center for Advancing Translational Sciences
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U24 Clinical Trial Not Allowed)
  (PAR-22-110)
  National Institute on Aging
  Application Receipt Date(s): Not Applicable
  
  

• Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)
  (PAR-22-111)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Required)
  (PAR-22-112)
  National Institute of Mental Health
  Application Receipt Date(s): December 23, 2022
  
  

• Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Optional)
  (PAR-22-113)
  National Institute of Mental Health
  Application Receipt Date(s): December 23, 2022
  
  

• Analgesic, Anesthetic and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks and Pediatric Anesthesia Safety Initiative (ACTTION/PASI) (U01) Clinical Trial Not Allowed)
  (RFA-FD-22-023)
  Food and Drug Administration
  Application Receipt Date(s): April 11, 2022, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
  
  

• Integrative Research in Gynecologic Health (R01 Clinical Trial Optional)
  (RFA-HD-23-006)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Office of Research on Women's Health
  Application Receipt Date(s): April 18, 2022
  
  

• HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes and Cells (U19 Clinical Trial Not Allowed)
  (RFA-NS-22-018)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): March 09, 2023
  
  

• HEAL Initiative: Human Pain-associated Genes and Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)
  (RFA-NS-22-021)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): March 09, 2023